Valvular heart disease secondary prevention: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Created page with "__NOTOC__ {{Valvular heart disease}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== {{...")
 
m (Bot: Removing from Primary care)
 
(4 intermediate revisions by 2 users not shown)
Line 2: Line 2:
{{Valvular heart disease}}
{{Valvular heart disease}}
Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]] to learn about editing.
Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]] to learn about editing.
==Overview==
==2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary<ref name="pmid24589852">{{cite journal| author=Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA et al.| title=2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. | journal=Circulation | year= 2014 | volume=  | issue=  | pages=  | pmid=24589852 | doi=10.1161/CIR.0000000000000029 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24589852  }} </ref>==
===Recommendations for The Heart Valve Team and Heart Valve Centers of Excellence===
{|class="wikitable"
|-
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]]
|-
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' Patients with severe valvular heart disease should be evaluated by a multidisciplinary heart valve team when intervention is considered.  ([[ACC AHA guidelines classification scheme#Level of Evidence|''Level of Evidence: C'']])<nowiki>"</nowiki>
|-
|}
{|class="wikitable"
|-
| colspan="1" style="text-align:center; background:LemonChiffon"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]]
|-
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.''' Consultation with or referral to a heart valve center of excellence is reasonable when discussing treatment options for:
* Asymptomatic patients with severe VHD,
* Patients who may benefit from valve repair versus valve replacement,
* Patients with multiple comorbidities for whom valve intervention is considered.  ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki>
|}
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WH}}
{{WS}}


[[Category:Needs content]]
[[Category:Needs content]]
[[Category:Cardiology]]
[[Category:Cardiology]]
[[Category:Valvular heart disease]]
[[Category:Valvular heart disease]]

Latest revision as of 00:38, 30 July 2020

Valvular heart disease Microchapters

Patient Information

Classification

Aortic stenosis
Aortic regurgitation
Mitral stenosis
Mitral valve prolapse
Mitral regurgitation
Tricuspid stenosis
Tricuspid regurgitation
Pulmonary stenosis
Pulmonary regurgitation

Differential Diagnosis

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary[1]

Recommendations for The Heart Valve Team and Heart Valve Centers of Excellence

Class I
"1. Patients with severe valvular heart disease should be evaluated by a multidisciplinary heart valve team when intervention is considered. (Level of Evidence: C)"
Class IIa
"1. Consultation with or referral to a heart valve center of excellence is reasonable when discussing treatment options for:
  • Asymptomatic patients with severe VHD,
  • Patients who may benefit from valve repair versus valve replacement,
  • Patients with multiple comorbidities for whom valve intervention is considered. (Level of Evidence: C)"


References

  1. ↑ Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA; et al. (2014). "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". Circulation. doi:10.1161/CIR.0000000000000029. PMID 24589852.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Valvular_heart_disease_secondary_prevention&oldid=1644453"